Literature DB >> 26557472

Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to Bedside.

Ali I Amjad1, Rahul A Parikh1, Leonard J Appleman1, Eun-Ryeong Hahm2, Kamayani Singh3, Shivendra V Singh2.   

Abstract

Sulforaphane (SFN) is a metabolic by product of cruciferous vegetables and is the biologically active phytochemical found in high concentrations in broccoli. It has been studied extensively for its anticancer efficacy and the underlying mechanisms using cell culture and preclinical models. The immediate precursor of SFN is glucoraphanin, a glucosinolate which requires metabolic conversion to SFN. SFN and other notable isothiocyanates, including phenethyl isothiocyanate and benzyl isothiocyanate found in various cruciferous vegetables, have also been implicated to have a chemopreventive role for breast, colon and prostate cancer. In-vitro and in-vivo anti-cancer activity of this class of compounds summarizing the past two decades of basic science research has previously been reviewed by us and others. The present review aims to focus specifically on SFN and its chemopreventive and antineoplastic activity against prostate cancer. Particular emphasis in this communication is placed on the current status of clinical research and prospects for future clinical trials with the overall objective to better understand the clinical utility of this promising chemopreventive nutraceutical in the context of mechanisms of prostate carcinogenesis.

Entities:  

Keywords:  Chemoprevention; Prostate cancer; Sulforaphane

Year:  2015        PMID: 26557472      PMCID: PMC4635516          DOI: 10.1007/s40495-015-0034-x

Source DB:  PubMed          Journal:  Curr Pharmacol Rep        ISSN: 2198-641X


  61 in total

Review 1.  Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes.

Authors:  J W Fahey; P Talalay
Journal:  Food Chem Toxicol       Date:  1999 Sep-Oct       Impact factor: 6.023

2.  Effect of dutasteride on the risk of prostate cancer.

Authors:  Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

3.  Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice.

Authors:  John D Clarke; Anna Hsu; David E Williams; Roderick H Dashwood; Jan F Stevens; Masayuki Yamamoto; Emily Ho
Journal:  Pharm Res       Date:  2011-06-17       Impact factor: 4.200

4.  Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation.

Authors:  Chengyue Zhang; Zheng-Yuan Su; Tin Oo Khor; Limin Shu; Ah-Ng Tony Kong
Journal:  Biochem Pharmacol       Date:  2013-02-14       Impact factor: 5.858

Review 5.  Protective effect of sulforaphane against oxidative stress: recent advances.

Authors:  Carlos Enrique Guerrero-Beltrán; Mariel Calderón-Oliver; José Pedraza-Chaverri; Yolanda Irasema Chirino
Journal:  Exp Toxicol Pathol       Date:  2010-12-03

6.  D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.

Authors:  Sunga Choi; Karen L Lew; Hui Xiao; Anna Herman-Antosiewicz; Dong Xiao; Charles K Brown; Shivendra V Singh
Journal:  Carcinogenesis       Date:  2006-08-18       Impact factor: 4.944

7.  Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.

Authors:  Shivendra V Singh; Renaud Warin; Dong Xiao; Anna A Powolny; Silvia D Stan; Julie A Arlotti; Yan Zeng; Eun-Ryeong Hahm; Stanley W Marynowski; Ajay Bommareddy; Dhimant Desai; Shantu Amin; Robert A Parise; Jan H Beumer; William H Chambers
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

8.  Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6.

Authors:  Angela Gibbs; Jacob Schwartzman; Vivianne Deng; Joshi Alumkal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

9.  Long-term survival of participants in the prostate cancer prevention trial.

Authors:  Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; Howard L Parnes; Lori M Minasian; Paul A Godley; M Scott Lucia; Leslie G Ford
Journal:  N Engl J Med       Date:  2013-08-15       Impact factor: 91.245

10.  Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy.

Authors:  W Weichert; A Röske; V Gekeler; T Beckers; C Stephan; K Jung; F R Fritzsche; S Niesporek; C Denkert; M Dietel; G Kristiansen
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

View more
  23 in total

1.  Sulforaphane Promotes Mitochondrial Protection in SH-SY5Y Cells Exposed to Hydrogen Peroxide by an Nrf2-Dependent Mechanism.

Authors:  Marcos Roberto de Oliveira; Flávia de Bittencourt Brasil; Cristina Ribas Fürstenau
Journal:  Mol Neurobiol       Date:  2017-07-20       Impact factor: 5.590

2.  Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial.

Authors:  Zhenzhen Zhang; Mark Garzotto; Edward W Davis; Motomi Mori; Wesley A Stoller; Paige E Farris; Carmen P Wong; Laura M Beaver; George V Thomas; David E Williams; Roderick H Dashwood; David A Hendrix; Emily Ho; Jackilen Shannon
Journal:  Nutr Cancer       Date:  2019-06-01       Impact factor: 2.900

3.  Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.

Authors:  Da-Xuan Wang; Yu-Jiao Zou; Xi-Bin Zhuang; Shu-Xing Chen; Yong Lin; Wen-Lan Li; Jun-Jin Lin; Zhi-Qiang Lin
Journal:  Acta Pharmacol Sin       Date:  2016-11-28       Impact factor: 6.150

4.  Retrospective and Prospective Look at Aflatoxin Research and Development from a Practical Standpoint.

Authors:  Noreddine Benkerroum
Journal:  Int J Environ Res Public Health       Date:  2019-09-27       Impact factor: 3.390

Review 5.  Molecular Regulation of Carcinogenesis: Friend and Foe.

Authors:  Andrew D Patterson; Frank J Gonzalez; Gary H Perdew; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2018-10-01       Impact factor: 4.849

6.  Fatty Acid Synthesis Intermediates Represent Novel Noninvasive Biomarkers of Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate.

Authors:  Krishna B Singh; Shivendra V Singh
Journal:  Cancer Prev Res (Phila)       Date:  2017-03-14

7.  A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells.

Authors:  Gavin S Johnson; Jia Li; Laura M Beaver; W Mohaiza Dashwood; Deqiang Sun; Praveen Rajendran; David E Williams; Emily Ho; Roderick H Dashwood
Journal:  Mol Nutr Food Res       Date:  2017-01-03       Impact factor: 5.914

Review 8.  Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer.

Authors:  Sharad S Singhal; Divya Jain; Preeti Singhal; Sanjay Awasthi; Jyotsana Singhal; David Horne
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-03-28       Impact factor: 10.680

9.  Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels.

Authors:  Mohsen Koolivand; Maryam Ansari; Fatemeh Piroozian; Soheila Moein; Kianoosh MalekZadeh
Journal:  Mol Biol Rep       Date:  2018-10-22       Impact factor: 2.316

Review 10.  Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression.

Authors:  Ailin Zhang; Jiawei Zhang; Stephen Plymate; Elahe A Mostaghel
Journal:  Horm Cancer       Date:  2016-01-21       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.